Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | SVP and CIO | March 18, 2024 | March 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date March 18, 2024 · Filed March 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,576.3102 |
Ending reported balance
After 2024-03-20 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-03-18 · Exercise / conversion · Acquired 2,100 · Balance 4,020.3102 F1: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Row 2 · 2024-03-18 · Tax withholding · Disposed 1,224 · Balance 2,796.3102 F1: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Row 3 · 2024-03-18 · Sale · Disposed 344 · Balance 2,452.3102 F1: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Row 4 · 2024-03-20 · Sale · Disposed 876 · Balance 1,576.3102 F1: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $101.16 · Expires 2028-01-31 | Direct | 4,190 |
Reported balance
After 2024-03-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-03-18 · Exercise / conversion · Disposed 2,100 · Balance 4,190 F1: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. F2: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.
F2: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2024 Filed Mar 20, 2024 17:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 876 | $330.25 | $289,299.00 |
DisclosureSEC source: 0001209191-24-004999 · doc4.xml · nonDerivative · entry 4 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,576.3102 F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 17:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 2,100 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-24-004999 · doc4.xml · derivative · entry 5 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,190 Underlying: Common Stock · 2,100 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 17:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 344 | $321.97 | $110,757.68 |
DisclosureSEC source: 0001209191-24-004999 · doc4.xml · nonDerivative · entry 3 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,452.3102 F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 17:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 1,224 | $327.17 | $400,456.08 |
DisclosureSEC source: 0001209191-24-004999 · doc4.xml · nonDerivative · entry 2 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,796.3102 F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 17:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 2,100 | $101.16 | $212,436.00 |
DisclosureSEC source: 0001209191-24-004999 · doc4.xml · nonDerivative · entry 1 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,020.3102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 19:35 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 499 | $308.55 | $153,966.45 |
DisclosureSEC source: 0001209191-24-003755 · doc4.xml · nonDerivative · entry 2 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,920.3102 Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 19:35 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 2,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003755 · doc4.xml · nonDerivative · entry 1 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,419.3102 F1 · kind: On February 3, 2021, the reporting person was granted 1,020 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:28 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 127 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002935 · doc4.xml · derivative · entry 4 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128 Underlying: Common Stock · 127 shares Expires 2031-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest in two equal annual installments beginning February 3, 2024. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:28 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 38 | $309.42 | $11,757.96 |
DisclosureSEC source: 0001209191-24-002935 · doc4.xml · nonDerivative · entry 3 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379.3102 F2 · balance_after: Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:28 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 127 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002935 · doc4.xml · nonDerivative · entry 2 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417.3102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert into common stock on a one-for-one basis. F2 · balance_after: Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:28 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 652 | $312.04 | $203,450.54 |
DisclosureSEC source: 0001209191-24-002935 · doc4.xml · nonDerivative · entry 1 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290.3102 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.0111 to $312.06, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.